Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS

L. S. Appiah-Kubi; S. Pal; K. Ray Chaudhuri

doi:10.1016/S1389-9457(02)00149-1

Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS

L. S. Appiah-Kubi, S. Pal, K. Ray Chaudhuri^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

In summary, RLS is a common condition with considerable morbidity that can present either as primary disease or secondary to other medical conditions. Its effect on the overall quality of life of the patient and the caregiver is unknown. RLS or RLS-type symptoms (nucturnal restlessness) occur in PD and require specific recognition and management. Whether RLS or nocturnal restlessness is secondary to the disease process of PD or to dopaminergic therapy for PD remains to be ascerteined. A high index of suspicion is required for prompt diagnosis, counselling, and ensuring that patients are adequately treated.

Original language	English
Pages (from-to)	S51-S55
Journal	Sleep medicine
Volume	3
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/S1389-9457(02)00149-1
Publication status	Published - Nov 2002

Keywords / Materials (for Non-textual outputs)

Dopaminergic therapy
Periodic leg movement
Restless legs syndrome

Access to Document

10.1016/S1389-9457(02)00149-1

Cite this

@article{039dc1ca426b4ed7bab18862ffe01587,

title = "Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS",

abstract = "In summary, RLS is a common condition with considerable morbidity that can present either as primary disease or secondary to other medical conditions. Its effect on the overall quality of life of the patient and the caregiver is unknown. RLS or RLS-type symptoms (nucturnal restlessness) occur in PD and require specific recognition and management. Whether RLS or nocturnal restlessness is secondary to the disease process of PD or to dopaminergic therapy for PD remains to be ascerteined. A high index of suspicion is required for prompt diagnosis, counselling, and ensuring that patients are adequately treated.",

keywords = "Dopaminergic therapy, Periodic leg movement, Restless legs syndrome",

author = "Appiah-Kubi, {L. S.} and S. Pal and Chaudhuri, {K. Ray}",

year = "2002",

month = nov,

doi = "10.1016/S1389-9457(02)00149-1",

language = "English",

volume = "3",

pages = "S51--S55",

journal = "Sleep medicine",

issn = "1389-9457",

publisher = "Elsevier",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS

AU - Appiah-Kubi, L. S.

AU - Pal, S.

AU - Chaudhuri, K. Ray

PY - 2002/11

Y1 - 2002/11

N2 - In summary, RLS is a common condition with considerable morbidity that can present either as primary disease or secondary to other medical conditions. Its effect on the overall quality of life of the patient and the caregiver is unknown. RLS or RLS-type symptoms (nucturnal restlessness) occur in PD and require specific recognition and management. Whether RLS or nocturnal restlessness is secondary to the disease process of PD or to dopaminergic therapy for PD remains to be ascerteined. A high index of suspicion is required for prompt diagnosis, counselling, and ensuring that patients are adequately treated.

AB - In summary, RLS is a common condition with considerable morbidity that can present either as primary disease or secondary to other medical conditions. Its effect on the overall quality of life of the patient and the caregiver is unknown. RLS or RLS-type symptoms (nucturnal restlessness) occur in PD and require specific recognition and management. Whether RLS or nocturnal restlessness is secondary to the disease process of PD or to dopaminergic therapy for PD remains to be ascerteined. A high index of suspicion is required for prompt diagnosis, counselling, and ensuring that patients are adequately treated.

KW - Dopaminergic therapy

KW - Periodic leg movement

KW - Restless legs syndrome

UR - http://www.scopus.com/inward/record.url?scp=0036863967&partnerID=8YFLogxK

U2 - 10.1016/S1389-9457(02)00149-1

DO - 10.1016/S1389-9457(02)00149-1

M3 - Article

AN - SCOPUS:0036863967

SN - 1389-9457

VL - 3

SP - S51-S55

JO - Sleep medicine

JF - Sleep medicine

IS - SUPPL. 1

ER -

Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS

Abstract

Keywords / Materials (for Non-textual outputs)

Access to Document

Other files and links

Fingerprint

Cite this